American Journal of Infection Control

Hand hygiene (HH) is one of the most effective measures for preventing infections and cross-transmission of pathogens in health care settings. The importance of HH has been emphasized by the increasing number of antibiotic-resistant organisms and the

Daily chlorhexidine gluconate (CHG) baths, using prepackaged cloths, is a well-supported evidence-based practice to reduce patient's risk of acquiring a central line associated bloodstream infection (CLABSI).1-3 However, compliance with this practice

Candida auris (C. auris), first described in 2009 in Japan, is a multidrug-resistant yeast and a source of health care-associated outbreaks globally, including the United States.1-6 C. auris causes a spectrum of conditions, from colonization to

Hand hygiene (HH) is one of the most effective measures for preventing infections and cross-transmission of pathogens in healthcare settings. The importance of HH has been emphasized by the increasing number of antibiotic-resistant organisms and the

Candida auris (C. auris), first described in 2009 in Japan, is a multidrug-resistant yeast and a source of healthcare-associated outbreaks globally, including the United States1-6. C. auris causes a spectrum of conditions, from colonization to

Infection prevention and surveillance training approaches for home infusion therapy have not been well defined. We interviewed home infusion staff who perform surveillance activities about barriers to and facilitators for central line-associated

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus.1 Considering that the virus is transmitted through an infected person's respiratory droplets, the spread of the disease has been quick, resulting in a

Among hospitalized US Veterans, the rate of non-ventilator associated hospital acquired pneumonia (NV-HAP) decreased between 2015 and 2020 then increased following the onset of COVID-19.1 This increase in NV-HAP rates could be driven by elevated risk

Health care associated infections (HAI) cause significant mortality, morbidity, and excess health care expenses worldwide.1 The estimated pooled prevalence of HAIs in developing countries is over 10%.2 In Turkey, the burden of HAIs is around 13%. HAI

“Infection prevention” and “epidemiology” were not words commonly heard in dinner table conversations, but the past 3 years have changed that. As professional societies working in these fields, we see the world’s collective focus on ways to prevent